Related Experiment Video
Updated: Jun 8, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Pharmacologic opportunities for HIV prevention
1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Clinical Pharmacology and Therapeutics
|October 1, 2010
Summary
Antiretroviral (ARV) drugs, while extending HIV-infected patients' life expectancy, are increasingly needed for HIV prevention. Pharmacology can optimize ARV use to curb transmission effectively.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Background:
- Antiretroviral (ARV) treatment innovations have significantly improved life expectancy for HIV-infected individuals.
- Despite treatment successes, HIV transmission rates are rising, highlighting a critical need for effective prevention strategies.
- Limited progress in microbicide and vaccine development underscores the importance of exploring ARVs for HIV prevention.
Purpose of the Study:
- To review current HIV infection prevention strategies.
- To explore the application of pharmacological principles in optimizing ARV use for HIV prevention.
- To address the gap in understanding ARV pharmacokinetic-pharmacodynamic relationships in the context of HIV prevention.
Main Methods:
- Review of current literature on HIV prevention strategies.
- Analysis of preliminary animal studies on topical and systemic ARVs.
- Examination of pharmacokinetic-pharmacodynamic (PK-PD) relationships relevant to ARV efficacy in prevention.
- Discussion of pharmacological tools for optimizing drug selection, dosing, and clinical trial design.
Main Results:
- Preliminary animal studies indicate promising results for both topical and systemic ARV use in HIV prevention.
- Current clinical trials for ARV-based HIV prevention may lack a comprehensive understanding of PK-PD relationships.
- Pharmacological approaches can inform the development of effective ARV-based prevention strategies.
Conclusions:
- ARVs hold significant potential as a tool for HIV prevention, complementing existing treatment strategies.
- A deeper understanding of ARV PK-PD relationships is crucial for designing efficient and effective clinical trials.
- Pharmacology offers essential tools to identify optimal ARVs, combinations, doses, and regimens for HIV prevention, thereby reducing transmission rates.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...